Allovir Inc ALVR:NASDAQ

Last Price$17.46NASDAQ Previous Close - Last Trade as of 4:00PM ET 11/30/21

Today's Change-0.01(0.06%)
Bid (Size)N/A (N/A)
Ask (Size)N/A (N/A)
Day Low / High$16.69 - 18.05
Volume157.1 K
 

Read more news Recent News

--SVB Leerink Adjusts Price Target on AlloVir to $37 from $41, Keeps Outperform Rating
9:20AM ET 11/08/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

AlloVir Shares Climb After Morgan Stanley Lifts Price Target
2:47PM ET 10/19/2021 MT Newswires

AlloVir (ALVR) shares were up about 11% on below average volume in Tuesday afternoon trading after Morgan Stanley lifted the price target on the...

--Morgan Stanley Adjusts Price Target on AlloVir to $48 From $47, Maintains Overweight Rating
10:39AM ET 10/12/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

AlloVir Secures FDA Orphan Drug Designation for Posoleucel in Hemorrhagic Cystitis
8:14AM ET 10/04/2021 MT Newswires

AlloVir (ALVR) said Monday that the US Food and Drug Administration has granted orphan drug designation to posoleucel, the company's investigational...

View all Commentary and Analysis

AlloVir, Inc.: Creating Solutions For Stem Cell Transplant Issues
12:53AM ET 10/02/2021 Seeking Alpha

Wall Street Breakfast: El Salvador Adopts Bitcoin (Podcast)
8:08AM ET 9/07/2021 Seeking Alpha

Wall Street Breakfast: Reddit Targets Bitcoin
6:36AM ET 9/07/2021 Seeking Alpha

Wall Street Breakfast: The Week Ahead (Podcast)
8:01AM ET 9/05/2021 Seeking Alpha

Company Profile

Business Description
Number of EmployeesN/A
Recent SEC Filing11/18/20214

Company Highlights

Price Open$17.38
Previous Close$17.46
52 Week Range$16.66 - 48.96
Market Capitalization$1.1 B
Shares Outstanding65.1 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement02/10/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$2.23
Beta vs. S&P 500N/A
RevenueN/A
Net Profit MarginN/A
Return on Equity-44.44%

Analyst Ratings as of 08/20/2021

Buy
4
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset